{"id":"1647194","title":"Eshbal Reports 2025 Results with Revenue Growth and Margin Improvement","author":null,"feed":"PRTGAM","feedName":"Newswire.ca","published":"Fri May 1, 8:08AM CDT","image":"N/A","content":"

TSXV: ESBL

VANCOUVER, BC, May 1, 2026 /CNW/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company") reports its financial results and MD&A for the year ended December 31, 2025.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

","related":[{"id":"2568540","title":"The Vanguard S&P 500 ETF (VOO) Is the Most Popular ETF in the World. Here's One I Like Even Better.","slug":"the-vanguard-sp-500-etf-voo-is-the-most-popular-etf-in-the-world-here-s-one-i-like-even-better","feedName":"Motley Fool","published":"4 minutes ago","categories":[]},{"id":"2568518","title":"Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?","slug":"should-you-buy-abbott-labs-stock-hand-over-fist-before-july-16","feedName":"Motley Fool","published":"18 minutes ago","categories":[]},{"id":"2568509","title":"12 Months From Now, Will You Wish You Bought SpaceX Today?","slug":"12-months-from-now-will-you-wish-you-bought-spacex-today","feedName":"Motley Fool","published":"28 minutes ago","categories":[]},{"id":"2568506","title":"Guosheng Securities Sticks to Its Buy Rating for Hansoh Pharmaceutical Group Company Limited (3692)","slug":"guosheng-securities-sticks-to-its-buy-rating-for-hansoh-pharmaceutical-group-company-limited-3692","feedName":"Tipranks","published":"30 minutes ago","categories":[]},{"id":"2568512","title":"Innodata vs. PAR Technology: Which Tech Specialist's Stock Is a Better Buy in 2026?","slug":"innodata-vs-par-technology-which-tech-specialist-s-stock-is-a-better-buy-in-2026","feedName":"Motley Fool","published":"31 minutes ago","categories":[]},{"id":"2568501","title":"Taking Your First RMD in 2026? Here's Why You Should Start It Now","slug":"taking-your-first-rmd-in-2026-here-s-why-you-should-start-it-now","feedName":"Motley Fool","published":"33 minutes ago","categories":[]},{"id":"2568440","title":"Nuclear Power Is Having a Moment, and These 3 Stocks Are the Best to Buy Right Now","slug":"nuclear-power-is-having-a-moment-and-these-3-stocks-are-the-best-to-buy-right-now","feedName":"Motley Fool","published":"48 minutes ago","categories":[]},{"id":"2568442","title":"This Metric From Google Cloud Proves Its $185 Billion in Capital Spending This Year Is Worth It","slug":"this-metric-from-google-cloud-proves-its-185-billion-in-capital-spending-this-year-is-worth-it","feedName":"Motley Fool","published":"52 minutes ago","categories":[]},{"id":"2568402","title":"Joby Aviation: Could This $9 Stock Help Make You a Millionaire?","slug":"joby-aviation-could-this-9-stock-help-make-you-a-millionaire","feedName":"Motley Fool","published":"1 hour ago","categories":[]}],"sourceId":"newswireca-2026-5-1-eshbal-reports-2025-results-with-revenue-growth-and-margin-improvement","media":"text","thumbnail":"N/A","canonicalUrl":"https://www.newswire.ca/news-releases/eshbal-reports-2025-results-with-revenue-growth-and-margin-improvement-893436100.html","feedUrl":null,"slug":"eshbal-reports-2025-results-with-revenue-growth-and-margin-improvement"}

Latest in

More

Eshbal Reports 2025 Results with Revenue Growth and Margin Improvement